II's, TR1's, relatively small number of shares?17 Nov 2020 09:08
Given the opportunities that Novacyt has now with care homes and other settings, ongoing (non-covid related) testing using the in place 16's and 32's and the fact that vaccine news (in my opinion) does not in any way negate the need for testing, would it not be on the radar for the bigger players? I'm getting happier by the week!